Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Differentiated Thyroid Gland Carcinoma”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)UnknownNCT04180007
What this trial is testing

Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

Who this might be right for
ThyroidMetastasisApatinib
Nanjing First Hospital, Nanjing Medical University 10
Testing effectiveness (Phase 2)Study completedNCT01173289
What this trial is testing

Study of External Beam Radiotherapy to Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
National Cancer Center, Korea 62
Early research (Phase 1)Study completedNCT01438554
What this trial is testing

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Who this might be right for
Solid TumorsThyroid CancerSoft-tissue Sarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 89
Testing effectiveness (Phase 2)Study completedNCT01723202
What this trial is testing

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

Who this might be right for
Follicular Thyroid CancerInsular Thyroid CancerPapillary Thyroid Cancer+1 more
Bhavana Konda 53
Not applicableUnknownNCT06062563
What this trial is testing

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
Peking Union Medical College Hospital 10
Early research (Phase 1)Looking for participantsNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057
What this trial is testing

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
West China Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848920
What this trial is testing

Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)Neoadjuvant Therapy
Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Testing effectiveness (Phase 2)Study completedNCT02731352
What this trial is testing

Study of Apatinib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 20
Not applicableUnknownNCT02156362
What this trial is testing

Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)

Who this might be right for
Thyroid Cancer
Hospices Civils de Lyon 643
Testing effectiveness (Phase 2)Looking for participantsNCT06359847
What this trial is testing

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 60
Not applicableLooking for participantsNCT06431620
What this trial is testing

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Who this might be right for
Recombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University 15
Early research (Phase 1)Active Not RecruitingNCT04420754
What this trial is testing

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerRelapsed/Refractory Poorly Differentiated Thyroid Cancer
AffyImmune Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00625846
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Differentiated Thyroid Gland Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03914300
What this trial is testing

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaPoorly Differentiated Thyroid Gland Carcinoma+6 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Load More Results